References
- 1. HJULER T., POULSEN G., WOHLFAHRT J., KALTOFT M., BIGGAR RJ., MELBYE M. Genetic Susceptibility to Severe Infection in Families with Invasive Pneumococcal Disease. Am J Epidemiol. 2008; 167(7):814–819.
- 2. WIERSINGA WJ., LEOPOLD SJ., CRANENDONK DR., VAN DER POLL T. Host innate immune responses to sepsis. Virulence. 2014; 5(1):36–44.
- 3. BOZZA F., SALLUH J., JAPIASSU A., SOARES M., ASSIS E., GOMES R., et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007; 11:R49.
- 4. STANILOVA SA. Functional relevance of IL-10 promoter polymorphisms for sepsis development. Crit Care. 2010; 14(1):119.
- 5. OUYANG L., LV YD., HOU C., WU GB., HE ZH. Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis. Mol Biol Rep. 2013; 40(7): 4327–4332.
- 6. ZENG L., GU W., CHEN K., JIANG D., ZHANG L., DU D., et al. Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. Crit Care. 2009, 13:R188.
- 7. STANILOVA SA., MITEVA LD., KARAKOLEV ZT., STEFANOV CS. Interleukin-10-1082 promoter polymorphism in association whith cytokine production and sepsis susceptibility. Intensive Care Med. 2006; 32(2): 260–266.
- 8. SHU Q., FANG X., CHEN Q., STUBER F. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin Med J (Engl). 2003; 116(11):1756–1759.
- 9. FAIX JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013; 50(1): 23–36.
- 10. SCHAAF BM., BOEHMKE F., ESNAASHARI H., SEITZER U., KOTHE H., MAASS M., et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med. 2003; 168(4): 476–480.
- 11. SINGER M., DEUTSCHMAN CS., SEYMOUR C., SHANKAR-HARI M., ANNANE D., BAUER MICHAEL., et al. The Third International Consensus Definitions for Sepsis and Septic Choque (Sepsis-3). JAMA. 2016; 315(8):801–810.
- 12. SCHULTE W., BERNHAGEN J., BUCALA R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets – an updated view. Mediators Inflamm. 2013; 2013:165974.
- 13. PAN W., ZHANG AQ., YUE CL., GAO JW., ZENG L., GU W., et al. Association between interleukin-10 polymorphisms and sepsis: a meta-analysis. Epidemiol Infect. 2015; 143(2): 366–375.
- 14. REINHART K. BAUER M., RIEDEMANN NC., HARTOG CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012; 25(4): 609–634.
- 15. KANG X., KIM HJ., RAMIREZ M., SALAMEH S., MA X. The septic shock-associated IL-10-1082 A>G polymorphism mediates allele-specific transcription via poly (ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells. J Immunol. 2010; 184(7): 3718–3724.
- 16. ABE R., HIRASAWA H., ODA S., SADAHIRO T., NAKAMURA M., WATANABE E., et al., Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J Surg Res. 2008; 147(1): 1–8.
- 17. SLIGL WI., DRAGAN T., SMITH SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Inf Dis. 2015; 37: 129–134.
- 18. PITTET D, LI N, WOOLSON RF, WENZEL RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, populationbased model. Clin Infect Dis 1997; 24: 1068–78.
- 19. SLIGL WI., DRAGAN T., SMITH SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Inf Dis. 2015; 37: 129–134.
- 20. STEINHAUSER ML., HOGABOAM CM., KUNKEL SL., LUKACS NW., STRIETER ROBERT M., et al. IL-10 Is a Major Mediator of Sepsis-Induced Impairment in Lung Antibacterial Host Defense. J. Immunol., 1999; 162: 392–399.
- 21. ACCARDO PALUMBO A., FORTE GI., PILERI D., VACCARINO L., CONTE F., D’AMELIO L., et al. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. Burns 2012, 38, 208–213.